[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1620 Introduced in House (IH)]
<DOC>
118th CONGRESS
1st Session
H. R. 1620
To promote affordable access to evidence-based opioid treatments under
the Medicare program and require coverage of medication assisted
treatment for opioid use disorders, opioid overdose reversal
medications, and recovery support services by health plans without
cost-sharing requirements.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 17, 2023
Ms. Dean of Pennsylvania (for herself and Mr. McGarvey) introduced the
following bill; which was referred to the Committee on Energy and
Commerce, and in addition to the Committee on Ways and Means, for a
period to be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the
committee concerned
_______________________________________________________________________
A BILL
To promote affordable access to evidence-based opioid treatments under
the Medicare program and require coverage of medication assisted
treatment for opioid use disorders, opioid overdose reversal
medications, and recovery support services by health plans without
cost-sharing requirements.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Maximizing Opioid Recovery Emergency
Savings Act'' or the ``MORE Savings Act''.
SEC. 2. TESTING OF ELIMINATION OF MEDICARE COST-SHARING FOR EVIDENCE-
BASED OPIOID TREATMENTS.
Section 1115A(b)(2) of the Social Security Act (42 U.S.C.
1315a(b)(2)) is amended--
(1) in subparagraph (A), in the last sentence, by inserting
``, and shall include the model described in subparagraph (D)
(which shall be implemented by not later than six months after
the date of the enactment of the Maximizing Opioid Recovery
Emergency Savings Act)'' before the period at the end; and
(2) by adding at the end the following new subparagraph:
``(D) Affordable access to evidence-based opioid
treatments.--
``(i) In general.--The model described in
this subparagraph is a model that seeks to
provide affordable access to evidence-based
opioid treatments and community-based recovery
support services by eliminating coinsurance,
copayments, and deductibles otherwise
applicable under parts B and D of title XVIII
(including as such parts are applied under part
C of such title) for the following items and
services that are otherwise covered under such
parts:
``(I) Drugs and biologicals
prescribed or furnished to treat opioid
use disorders or reverse overdose.
``(II) Behavioral health and
community support services furnished
for the treatment of opioid use
disorders, including treatment of
addiction in non-hospital residential
facilities licensed to furnish such
treatment.
``(III) Recovery support services
to maintain a healthy lifestyle
following opioid misuse treatment, such
as peer counseling and transportation.
``(ii) Selection of sites.--The CMI shall
select 15 States in which to conduct the model
under this subparagraph. A State shall meet
each of the following criteria in order to be
selected under the preceding sentence:
``(I) The State has a high
proportion of Medicare beneficiaries.
``(II) The State has a high rate of
overdose deaths due to opioids.
``(III) The State has a significant
percentage of rural areas.
``(iii) Termination and modification
provision not applicable for first five years
of the model.--The provisions of paragraph
(3)(B) shall apply to the model under this
subparagraph beginning on the date that is five
years after such model is implemented, but
shall not apply to such model prior to such
date.''.
SEC. 3. COVERAGE OF OPIOID TREATMENTS.
(a) In General.--Title XXVII of the Public Health Service Act is
amended by inserting after section 2719A (42 U.S.C. 300gg-19a) the
following:
``SEC. 2720. COVERAGE OF OPIOID TREATMENTS.
``A group health plan and a health insurance issuer offering group
or individual health insurance coverage shall, at a minimum, provide
coverage for and shall not impose any cost-sharing requirements for--
``(1) prescription drugs for the treatment of opioid use
disorders or to reverse overdose;
``(2) behavioral health services for the treatment of
opioid use disorders, including treatment of opioid use
disorders in non-hospital residential facilities licensed to
provide such treatment; or
``(3) community recovery support services that are provided
in conjunction with, where appropriate, medication-assisted
treatment for an opioid use disorder, such as peer counseling
and transportation, to support the enrollee in maintaining a
healthy lifestyle following opioid misuse treatment.''.
(b) Effective Date.--The amendment made by subsection (a) shall
apply with respect to plan years beginning on or after January 1, 2025.
SEC. 4. ENHANCED FEDERAL MATCH FOR MEDICATION-ASSISTED TREATMENT AND
RECOVERY SUPPORT SERVICES UNDER MEDICAID.
(a) In General.--Section 1905(b) of the Social Security Act (42
U.S.C. 1396d(b)) is amended by adding at the end the following:
``Notwithstanding the first sentence of this subsection, during the
portion of the period described in subsection (a)(29) that begins on
the date of enactment of this sentence, the Federal medical assistance
percentage shall be 90 percent with respect to amounts expended during
such portion of such period by a State that is one of the 50 States or
the District of Columbia as medical assistance for medication-assisted
treatment (as defined in subsection (ee)(1)).''.
(b) State Option To Provide Recovery Support Services as Part of
Medication-Assisted Treatment.--Section 1905(ee)(1) of the Social
Security Act (42 U.S.C. 1396d(ee)(1)) is amended--
(1) in subparagraph (A), by striking ``; and'' and
inserting a semicolon;
(2) in subparagraph (B), by striking the period at the end
and inserting ``; and''; and
(3) by adding at the end the following new subparagraph:
``(C) at the option of a State, includes recovery
support services, such as peer counseling and
transportation, that are provided to an individual in
conjunction with the provision of such drugs and
biological products to support the individual in
maintaining a healthy lifestyle following opioid misuse
treatment.''.
<all>